07Aug/13

Afinitor® in liver cancer does not meet primary endpoint of overall survival – Pharmacy Europe


Medical Daily

Afinitor® in liver cancer does not meet primary endpoint of overall survival
Pharmacy Europe
Novartis has announced that results of a global Phase III study showed that Afinitor® (everolimus) did not extend overall survival compared to placebo in patients with locally advanced or metastatic hepatocellular carcinoma (HCC) after progression on
Novartis Drug Afinitor Fails In Tests Against Liver CancerMedical Daily
Novartis drug doesn’t extend overall survival of patients with liver cancerMedCity News
Novartis’ ambitions for Afinitor suffer on liver-cancer failureFiercePharma
PMLiVE –Seeking Alpha
all 7 news articles »
07Aug/13

Pundit Brolly hits out over Seanad recall in organ donor row – Irish Independent


Irish Independent

Pundit Brolly hits out over Seanad recall in organ donor row
Irish Independent
Mr Brolly, who gave a kidney to friend and fellow GAA coach Shane Finnegan – although the transplant failed – supports an opt-out system of organ donation, which the Government is proposing. This means everyone starts out as a donor but people who do 
Seanad likely to be recalled to discuss law on organ donationIrish Times
Galway Senator signs consent to recall SeanadGalway Bay FM

all 5 news articles »